Over the years the majority of our customers have chosen our 300-unit t:slim X2™ insulin pump and as a result, demand for the 480-unit t:flex® insulin pump has not been enough to support its continued development.
We are confident that those who are interested in the t:flex insulin pump will love our advanced t:slim X2 insulin pump with Basal-IQ technology.
Current t:flex insulin pump user?
Rest assured, we will continue to provide t:flex cartridges, compatible infusion sets, and our top-rated, 24/7 customer support for the entire length of your warranty.
t:flex User Guide
*If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
1. Dexcom G6 continuous glucose monitor (CGM) sold separately. Transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 Pump) and one consumer device (phone or tablet) at the same time.
2. Additional feature updates are not currently available for the t:slim X2 Insulin Pump with Basal-IQ Technology and are subject to future FDA approvals. A prescription and additional training may be required to access certain future software updates. Charges may apply.
RX ONLY. The t:slim X2 insulin pump with Basal-IQ technology (the System) consists of the t:slim X2 insulin pump, which contains Basal-IQ technology, and a compatible continuous glucose monitor (CGM). CGM sold separately. The t:slim X2 insulin pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The t:slim X2 insulin pump can be used solely for continuous insulin delivery and as part of the System. When the System is used with a compatible iCGM, Basal-IQ technology can be used to suspend insulin delivery based on CGM sensor readings. Interpretation of the System results should be based on the trends and patterns seen with several sequential readings over time. CGM also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. Compatible iCGM systems are intended for single patient use and require a prescription. The System is indicated for use in individuals 6 years of age and greater. The System is intended for single patient use and requires a prescription. The System is indicated for use with NovoLog or Humalog U-100 insulin. The System is not approved for use in pregnant women, persons on dialysis, or critically ill patients. For detailed indications for use and safety information, call Tandem toll-free at (877) 801-6901 or visit www.tandemdiabetes.com/safetyinfo.